These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 19534872)

  • 1. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of moderate lead poisoning on the hippocampus tissue of rabbits in juvenile stage].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Wu SH; Xu J; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Mar; 42(3):160-4. PubMed ID: 18788578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chelated lead in relation to lead in bone and ALAD genotype.
    Gerhardsson L; Börjesson J; Mattsson S; Schütz A; Skerfving S
    Environ Res; 1999 May; 80(4):389-98. PubMed ID: 10330313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
    Lasky RE; Laughlin NK; Luck ML
    Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of micronutrients used along with DMSA in the treatment of moderately lead intoxicated mice.
    Liao Y; Yu F; Jin Y; Lu C; Li G; Zhi X; An L; Yang J
    Arch Toxicol; 2008 Jan; 82(1):37-43. PubMed ID: 17721779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic occupational lead poisoning with dimercaptosuccinic acid (DMSA)].
    Grandjean P; Jacobsen IA; Jørgensen PJ; Lings S; Andersen O
    Ugeskr Laeger; 1991 Oct; 153(41):2897-9. PubMed ID: 1659012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficiency of succimer used with calcium and ascorbic acid in the treatment of mild lead-poisoning.
    Jin Y; Yu F; Liao Y; Liu S; Liu M; Xu J; Yang J
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):137-42. PubMed ID: 21787678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.